Smoking CessationNCT06912113
The Effect of Motivational ınterviewing on ıntention to Quit Smoking in Lung Cancer Patients
A study testing Motivational interviewing in people with Smoking Cessation and Motivational Enhancement, run by University of Gaziantep at 1 site in Turkey (Türkiye).
Trial summary
The effect of online video conferencing on smoking cessation intention in patients diagnosed with lung cancer was investigated. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Smoking Cessation, Motivational Enhancement, İntention to Quit
- What is being tested?
- Motivational interviewing
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 29 Mar 2024to 31 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients over the age of 18,
- diagnosed with lung cancer, who had smoked at least 100 cigarettes in their lifetime and had smoked at least one cigarette in the last month,
- who volunteered to participate in the study,
- who had no communication problems, and who had internet access were included in the study.
Who cannot join
- Occasional smokers,
- Those using a different type of nicotine than cigarettes,
- Those actively participating in other smoking cessation programs, and those reporting dependence on any medication were excluded from the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Motivational Interviewing on Smoking Quit Intention in Lung Cancer Patients: a Randomized Controlled Trial
The effect of online video conferencing on smoking cessation intention in patients diagnosed with lung cancer was investigated.
- Being tested
- Motivational interviewing
- Keywords
- Motivational enhancement, Real-time video counselling, Lung cancer, İntention to quit smoking
- Medical subject headings
- Smoking Cessation, Lung Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motivational interviewingBehavioural
What distinguishes this intervention from other clinical applications is that in this study, the clinical effectiveness of motivational interviewing was examined by using a smoking cessation intention scale before and after the intervention.
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | No intervention was made to this arm, routine maintenance procedure was applied. |
| Intervention | Experimental | In this study, an online motivational interview was conducted over the real-time video counselling regarding quitting smoking. Receives: Behavioral: Motivational interviewing |
What is being measured
The primary outcome is the main question the study is designed to answer.
Intention to quit smoking scale
It was developed by Söyler et al. to measure the intention to quit smoking in smokers and consists of eight questions. The scoring of the scale is carried out by summing the scores obtained for each item. The scale includes the following questions: 1. I plan to quit smoking, 2. I will try to quit smoking, 3. I dream about quitting smoking, 4. I want to quit smoking, 5. Quitting smoking is important to me, 6. I will quit smoking soon, 7. I am doing research on quitting smoking, 8. I intend to meet with a health professional about quitting smoking. The questions in the scale were evaluated with a five-point Likert. Cronbach's alpha value is 0.929. The minimum score that can be obtained from the scale is 8, and the maximum score is 40. Increasing scores indicate an increasing intention to quit smoking, while decreasing scores indicate a decreasing intention to quit smoking.
Measured: Four weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Apr 2025
- Study start29 Mar 2024
- Primary completion31 Dec 2024
- Study completion31 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Smoking CessationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized controlled trial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Gaziantep
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sibel Doğru, University of Gaziantep
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06912113
- Sponsor's protocol ID
- 2024/92
- Status last verified
- Feb 2026
- First submitted
- 20 Mar 2025
- Last updated
- 20 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Dogru S, Aytac S, Ovayolu O. The effect of motivational interviewing on smoking cessation intention in patients with lung cancer: A randomized controlled trial. Tob Induc Dis. 2026 Aug 1;24. doi: 10.18332/tid/219211. eCollection 2026.
PubMed 42569500
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Motivational Interviewing on Smoking Quit Intention in Lung Cancer Patients: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06912113
- Acronym / sponsor ID
- 2024/92
- Keywords
- Motivational enhancement, Real-time video counselling, Lung cancer, İntention to quit smoking
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- University of GaziantepUniversity, hospital or other
- Study start
- 29 Mar 2024 (actual)
- Primary completion
- 31 Dec 2024 (actual)
- Study completion
- 31 Dec 2024 (actual)
- First posted
- 4 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The effect of online video conferencing on smoking cessation intention in patients diagnosed with lung cancer was investigated.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –No intervention was made to this arm, routine maintenance procedure was applied. |
| Intervention | Experimental | Behavioral: Motivational interviewingIn this study, an online motivational interview was conducted over the real-time video counselling regarding quitting smoking. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients over the age of 18,
- diagnosed with lung cancer, who had smoked at least 100 cigarettes in their lifetime and had smoked at least one cigarette in the last month,
- who volunteered to participate in the study,
- who had no communication problems, and who had internet access were included in the study.
Key exclusion criteria (3 listed)
- Occasional smokers,
- Those using a different type of nicotine than cigarettes,
- Those actively participating in other smoking cessation programs, and those reporting dependence on any medication were excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motivational interviewingWhat distinguishes this intervention from other clinical applications is that in this study, the clinical effectiveness of motivational interviewing was examined by using a smoking cessation intention scale before and after the intervention. | Behavioural | Intervention |
Primary outcome
Intention to quit smoking scale
Time frame: Four weeks
It was developed by Söyler et al. to measure the intention to quit smoking in smokers and consists of eight questions. The scoring of the scale is carried out by summing the scores obtained for each item. The scale includes the following questions: 1. I plan to quit smoking, 2. I will try to quit smoking, 3. I dream about quitting smoking, 4. I want to quit smoking, 5. Quitting smoking is important to me, 6. I will quit smoking soon, 7. I am doing research on quitting smoking, 8. I intend to meet with a health professional about quitting smoking. The questions in the scale were evaluated with a five-point Likert. Cronbach's alpha value is 0.929. The minimum score that can be obtained from the scale is 8, and the maximum score is 40. Increasing scores indicate an increasing intention to quit smoking, while decreasing scores indicate a decreasing intention to quit smoking.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2026.
- Derived from this study: PubMed 42569500Dogru S, Aytac S, Ovayolu O. The effect of motivational interviewing on smoking cessation intention in patients with lung cancer: A randomized controlled trial. Tob Induc Dis. 2026 Aug 1;24. doi: 10.18332/tid/219211. eCollection 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Smoking Cessation
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Not yet recruitingObservational study
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Smoking Cessation, Lung Cancer Screening
Not yet recruiting
Impacto 2.0: Mobile Smoking Cessation Across Texas
Cigarette Smoking, Smoking Cessation
Not yet recruiting
Smoking Cessation Program for Lao People With HIV
Smoking Cessation, HIV
RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Motivational interviewing in people with Smoking Cessation and Motivational Enhancement, run by University of Gaziantep at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Intention to quit smoking scale (time frame: Four weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06912113, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.